Komuro I, Kadowaki T, Bodegard J, Thuresson M, et al. Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases. Diabetes Obes Metab 2021;23 Suppl 2:19-27.
PMID: 33835641